Indian Prime Minister Narendra Modi has expressed "strong concerns" over Canada's handling of the Punjabi independence movement among the overseas diaspora, on the same day thousands in Metro Vancouver's Sikh community gathered to vote on the matter. [CP]
Le Bloc québécois mettra les bouchées doubles cette semaine dans l’espoir d’envoyer un signal fort à l’Estrie, une région où le parti souhaite faire des gains aux dépens des libéraux lors des prochaines élections générales. [La Presse]
The provincial government says it can't say exactly how long it has been using an encrypted message service "with privacy at its core" and which allows messages to be permanently deleted. [Telegraph-Journal]
[Researchers] find a strong positive treatment effect concentrated on a minority of individuals who correctly answered a factual manipulation check regarding the endorsements. Our results suggest that though only a fraction of individuals appear to pay conscious attention to endorsement metrics, they may be influenced by these social cues. [Social Media + Society]
The new shots are expected to be available later this week, after the Centers for Disease Control and Prevention signs off. Health Canada officials will speak this morning about COVID boosters in this country. [NBC]
The question of why we didn’t get a malaria vaccine sooner isn’t just an intellectual exercise – around 600,000 people die from the disease each year – and its answer isn’t just a scientific one. The malaria parasite is complex, making it much more difficult to develop a vaccine than usual. But at the heart of the issue, especially in recent decades, was a lack of financial incentive and urgency. Malaria primarily affects the global poor, whose ability to spend on healthcare is limited. Companies who invent solutions for the poor face pressure to keep prices so low that it is hard to profit, on top of the fact that vaccines tend to make less money than other medicines.
Advance Market Commitments, a way of promising to buy products that don’t yet exist, could help overcome these barriers, encourage investment in vaccines for other diseases, and improve on the vaccines we currently have. [Works in Progress]